Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Deutsches Diabeteszentrum (DDZ), Leibniz-Institut Düsseldorf | UNKNOWN |
| Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, TU Dresden | UNKNOWN |
| Klinik für Diabetologie an der Medizinischen Klinik - Innenstadt, LMU München |
Not provided
Not provided
Not provided
Not provided
Due to a changed lifestyle with less physical activity, unfavorable diets rich in fat and calories and obesity, the prevalence of diabetes mellitus is increasing worldwide. The diabetes epidemic is associated with significant personal and socio-economic consequences. Despite attempts to prevent the complications of diabetes, this disease is still the leading cause of blindness, chronic renal insufficiency and non-traumatic amputation. It is important to detect early on an increase in blood sugar and treat it accordingly to reduce costs and to minimize the personal suffering of those affected. As the number of patients with type 2 diabetes mellitus continues to rise, the number of young women with gestational diabetes mellitus (GDM) also increases. This is a disorder og glucose metabolism, which occurs for the first time in pregnancy. The causes for this are manifold. Among other causes, the increasing age of the mothers and weight gain during pregnancy are risk factors for gestational diabetes. Although it has been recommended that women with gestational diabetes should be re-examined after the birth of their child, many women have not. The study is a follow-up study to clarify whether insulin secretion disorder in women with and after GDM is a risk factor for the occurrence of type 2 diabetes mellitus.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women with GDM | |||
| Women without GDM |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Glucose tolerance during 75 g oral glucose tolerance test | Glucose tolerance, insulin sensitivity and insulin secretion during oral glucose tolerance test | Glycemia from start of glucose tolerance test (0 minutes) until the end (120 minutes) |
| Measure | Description | Time Frame |
|---|---|---|
| Glucose tolerance during 75 g oral glucose tolerance test 1, 2, 5, 10 years postpartum | Glucose tolerance during oral glucose tolerance test | Glycemia from start of glucose tolerance test (0 minutes) until the end (120 minutes) |
| Body fat distribution |
Not provided
Inclusion Criteria:
- Signed and dated informed consent
Enrollment is possible during AND after gestation:
Exclusion Criteria:
Not provided
Not provided
Not provided
Pregnant women in gestational week 24+0 till 31+6 and women postpartum who had a documented occurence of GDM in previous pregnancy.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andreas Fritsche, MD | Contact | +49 7071 29 | 82711 | andreas.fritsche@med.uni-tuebingen.de |
| Louise Fritsche, PhD | Contact | +49 7071 29 | 82711 | louise.fritsche@med.uni-tuebingen.de |
| Name | Affiliation | Role |
|---|---|---|
| Andreas Fritsche, MD | University Hospital Tuebingen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Tuebingen | Recruiting | Tübingen | 72076 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35226999 | Derived | Bauer I, Schleger F, Hartkopf J, Veit R, Breuer M, Schneider N, Pauluschke-Frohlich J, Peter A, Preissl H, Fritsche A, Fritsche L. Pre-pregnancy BMI but not mild stress directly influences Interleukin-6 levels and insulin sensitivity during late pregnancy. Front Biosci (Landmark Ed). 2022 Feb 12;27(2):56. doi: 10.31083/j.fbl2702056. | |
| 35180296 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
| Universitätsklinik Heidelberg, Abteilung Innere Medizin I, Schwerpunkt Endokrinologie und Stoffwechsel | UNKNOWN |
| Universitätsklinikum Leipzig, IFB Adipositas Erkrankungen | UNKNOWN |
Not provided
Not provided
Not provided
Measurement of body fat distribution by MRS
| Once during pregnancy and 1, 2, 5, and 10 years postpartum |
| Spiroergometry to assess physical fitness | Measurement of VO2max (l/min/kg) as a proxy for physical fitness | 1, 2, 5, and 10 years postpartum |
| BIA (bioimpedance analysis) | BIA to estimate body fat (%) | Once during pregnancy and 1, 2, 5, and 10 years postpartum |
| BMI | Measurement of weight (kg) and height (m) and given as kg/m^2 | Once during pregnancy and 1, 2, 5, and 10 years postpartum |
| Assessment of cognitive abilities in offspring | Cognitive skills represented as an intelligence quotient will be assessed Wechsler Intelligence Scale for Children - Fifth Edition (WISC-V) | 6 and 10 years postpartum |
| Assessment of cognitive, motoric and language development in offspring | Cognitive, motoric and language development of children will be assessed with the Bayley Scales of Infant and Toddler Development - Third Edition (Bayley-III) | 2 years postpartum |
| BIA in offspring | BIA to estimate body composition in offspring | 2, 6 and 10 years postpartum |
| Electrocardiogram | 10 minute ECG to assess RR distance for calculation of heart rate variability (R wave distance in ms) | 2, 6 and 10 years postpartum |
| blood sample | blood sample to assess HbA1C | 6 and 10 years postpartum |
| Fritsche L, Heni M, Eckstein SS, Hummel J, Schurmann A, Haring HU, Preissl H, Birkenfeld AL, Peter A, Fritsche A, Wagner R. Incretin Hypersecretion in Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2022 May 17;107(6):e2425-e2430. doi: 10.1210/clinem/dgac095. |
| 35168986 | Derived | Fritsche L, Hummel J, Wagner R, Loffler D, Hartkopf J, Machann J, Hilberath J, Kantartzis K, Jakubowski P, Pauluschke-Frohlich J, Brucker S, Horber S, Haring HU, Roden M, Schurmann A, Solimena M, de Angelis MH, Peter A, Birkenfeld AL, Preissl H, Fritsche A, Heni M. The German Gestational Diabetes Study (PREG), a prospective multicentre cohort study: rationale, methodology and design. BMJ Open. 2022 Feb 15;12(2):e058268. doi: 10.1136/bmjopen-2021-058268. |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D006946 | Hyperinsulinism |